查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1172026

基因組市場的全球人工智能:按產品、按功能、按應用、按交付模式,按最終用戶預測 (-2029)

AI in Genomics Market by Offering (Software, Services), Functionality (Sequencing, Gene Editing), Application (Diagnostics, Precision Medicine, Drug Discovery and Development), Delivery Mode (On-premise, Cloud), and End User-Global Forecast to 2029
出版日期: | 出版商: Meticulous Research | 英文 162 Pages | 訂單完成後即時交付

價格

在 2022 年至 2029 年的預測期內，全球 AI 基因組學市場規模預計將以 42.8% 的複合年增長率增長，到 2029 年將達到 62.2 億美元。 推動市場增長的關鍵因素包括越來越關注減少藥物發現和開發周轉時間、增加人工智能在醫療保健/基因組學中的使用、增加對人工智能的投資、新興初創企業以及機器學習 (ML) 的日益普及在個性化/精準醫學中。

本報告按產品、功能、應用和交付模式檢查了基因組學市場的全球人工智能，包括市場概況、市場規模和預測、趨勢、驅動因素和製約因素、競爭格局。我們按個人提供分析、最終用戶、地理位置和公司概況。

內容

第一章介紹

  • 市場定義
  • 市場生態系統
  • 貨幣
  • 主要利益相關者

第二章研究方法論

  • 研究過程
  • 數據收集和驗證
    • 二次調查
    • 初步調查
  • 市場評估
    • 市場規模估算
    • 市場份額分析
  • 調查先決條件
  • 調查限制

第 3 章執行摘要

第 4 章市場洞察

  • 介紹
  • 司機
    • 對縮短藥物發現的周轉時間越來越感興趣
    • 增加對基因組學的投資
    • 基因組學及其應用對人工智能的需求不斷增加
  • 約束因素
    • 將人工智能整合到基因組學中的資源有限
  • 機會
    • 新興國家
    • 對開發個性化醫療越來越感興趣
  • 任務
    • 基因組學軟件的模糊監管指南
    • 大量基因組測序數據的存儲和安全性不足
  • COVID-19 的影響

第 5 章全球 AI 基因組學市場:通過提供

  • 介紹
  • 軟件
  • 服務

第 6 章全球基因組學 AI 市場:按交付模式

  • 介紹
  • 雲/基於網絡的模式
  • 本地模式

第 7 章全球基因組學 AI 市場:按功能分類

  • 介紹
  • 基因組測序
  • 基因編輯
  • 其他

第 8 章基因組學全球 AI 市場:按應用

  • 介紹
  • 藥物發現和開發
  • 精準醫學
  • 診斷
  • 其他

第 9 章全球基因組學 AI 市場:按最終用戶分類

  • 介紹
  • 製藥和生物技術公司
  • 學術和研究機構
  • 其他

第 10 章基因組學 AI 市場:按地區

  • 介紹
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲

第11章競爭格局

  • 介紹
  • 主要發展戰略
  • 競爭基準
  • 市場份額分析（2021 年）
    • 英偉達公司
    • 微軟公司
    • Illumina, Inc.

第 12 章公司簡介（業務概述、財務概述、解決方案組合、戰略發展）

  • Microsoft Corporation
  • NVIDIA Corporation
  • Deep Genomics Incorporated
  • Fabric Genomics, Inc.
  • Data4cure, Inc.
  • Predictive Oncology Inc.
  • Emedgene Technologies Ltd
  • Congenica Ltd.
  • Tempus Labs, Inc.
  • SOPHiA GENETICS SA
  • Illumina, Inc.
  • BenevolentAI Limited

第13章 附錄

Product Code: MRHC - 104660

The AI in genomics market is expected to reach $6.22 billion by 2029, at a CAGR of 42.8% from 2022 to 2029.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report studies the key industry drivers, restraints, challenges, and opportunities. The growth of the AI in genomics market is attributed to the rising focus on reducing turnaround time in drug discovery & development, increasing use of AI in healthcare/genomics, and growing investments in AI. In addition, emerging start-ups and the rising adoption of machine learning (ML) in personalized/precision medicine are likely to offer opportunities for market growth.

Based on offering, in 2022, the software segment is estimated to account for the largest share of the market. The key factors attributed to this segment's large market share are the growing adoption of AI in healthcare/genomics and the advancements in AI algorithms to analyze huge amounts of genetic datasets. For instance, in April 2022, MedGenome (U.S.) launched an AI-enabled variant interpretation software suit, VarMiner, to help clinicians, genome analysts, and molecular geneticists interpret and report variants. In the other instance, in October 2020, Fabric Genomics (U.S.) launched Fabric GEM to accelerate genetic disease diagnosis and provide comprehensive clinical-decision support.

The AI in genomics market is segmented by offering (software, services), delivery mode (on-premises, cloud & web-based), functionality (genome sequencing, gene editing, other functionalities), application (drug discovery and development, precision medicine, diagnostics, and other applications), end user (pharmaceutical & biopharmaceutical companies, academic & research institutes, and other end users), and geography. The study also evaluates industry competitors and analyzes their market shares at global and regional levels.

Based on functionality, in 2022, the genome sequencing segment is estimated to account for the largest share of the market. The factors attributing to the large market share of this segment are the increasing adoption of AI in genome sequencing studies and the growing R&D related to COVID-19.

Based on application, the market is segmented into drug discovery and development, precision medicine, diagnostics, and other applications. In 2022, the drug discovery and development segment is estimated to account for the largest share of the market. The key factors attributing to the large market share of this segment are the growing adoption of AI algorithms in drug discovery and the growing collaboration between pharmaceutical/biopharmaceutical companies and companies that provide AI solutions.

Based on end user, the pharmaceutical & biopharmaceutical companies segment is estimated to account for the largest share of the market. These companies use AI algorithms to speed up drug discovery. Furthermore, the increasing burden of chronic and infectious diseases is burdening pharmaceutical companies to speed up drug discovery. Thus, the highest adoption of AI in genomics solutions by pharmaceutical and biopharmaceutical companies contributes to this segment's large market share.

An in-depth analysis of the geographical scenario of the AI in genomics provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2022, North America is estimated to account for the largest share of the AI in genomics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The increasing research initiatives in genomics, the availability of infrastructure for genomics research and AI, and the growing adoption of AI in precision medicine to meet the increasing market demand are the factors contributing to the large market share of this region.

Some of the key players operating in the global AI in genomics are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

Scope of the Report:

Global AI in Genomics Market, by Offering

  • Software
  • Services

Global AI in Genomics Market, by Delivery Mode

  • On-premises
  • Cloud & Web-Based Mode

Global AI in Genomics Market, by Functionality

  • Genome Sequencing
  • Gene Editing
  • Other Functionalities

Note: Other functionalities include pharmacogenomics and predictive gene testing.

Global AI in Genomics Market, by Application

  • Drug Discovery & Development
  • Precision Medicine
  • Diagnostics
  • Other Applications

Note: Other applications include agriculture, pharmacology, and animal health.

Global AI in Genomics Market, by End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic & Research Institutes
  • Other End Users

Note: Other end users include contract research organizations and agriculture companies.

Global AI in Genomics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-up Approach
      • 2.3.1.2. Top-down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Rising Focus on Reducing Turnaround Time in Drug Discovery
    • 4.2.2. Increasing Investment in Genomics
    • 4.2.3. Growing Need for and Application of AI in Genomics
  • 4.3. Restraints
    • 4.3.1. Limited Availability of Resources for Integration of Artificial Intelligence in Genomics
  • 4.4. Opportunity
    • 4.4.1. Emerging Economies
    • 4.4.2. Rising Focus on the Development of Personalized Medicines
  • 4.5. Challenges
    • 4.5.1. Ambiguous Regulatory Guidelines for Genomics Software
    • 4.5.2. Poor Security & Storage of Large Volumes of Genome Sequencing Data
  • 4.6. Impact of COVID-19

5. Global Artificial Intelligence in Genomics Market, by Offering

  • 5.1. Introduction
  • 5.2. Software
  • 5.3. Services

6. Global Artificial Intelligence in Genomics, by Delivery Mode

  • 6.1. Introduction
  • 6.2. Cloud & Web-based Mode
  • 6.3. On-premise Mode

7. Global Artificial Intelligence in Genomics, by Functionality

  • 7.1. Introduction
  • 7.2. Genome Sequencing
  • 7.3. Gene Editing
  • 7.4. Other Functionalities

8. Global Artificial Intelligence in Genomics Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Discovery & Development
  • 8.3. Precision Medicine
  • 8.4. Diagnostics
  • 8.5. Other Applications

9. Global Artificial Intelligence in Genomics Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Academic & Research Institutes
  • 9.4. Other End Users

10. Artificial Intelligence in Genomics Market, by Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U. S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Market Share Analysis (2021)
    • 11.4.1. NVIDIA Corporation (U.S.)
    • 11.4.2. Microsoft Corporation (U.S.)
    • 11.4.3. Illumina, Inc. (U.S.)

12. Company Profiles (Business Overview, Financial Overview, Solutions Portfolio, Strategic Developments)

  • 12.1. Microsoft Corporation
  • 12.2. NVIDIA Corporation
  • 12.3. Deep Genomics Incorporated
  • 12.4. Fabric Genomics, Inc.
  • 12.5. Data4cure, Inc.
  • 12.6. Predictive Oncology Inc.
  • 12.7. Emedgene Technologies Ltd
  • 12.8. Congenica Ltd.
  • 12.9. Tempus Labs, Inc.
  • 12.10. SOPHiA GENETICS SA
  • 12.11. Illumina, Inc.
  • 12.12. BenevolentAI Limited

13. Appendix

  • 13.1. Questionnaire
  • 13.2. Available Customization

List of Tables

  • Table 1 Global AI in Genomics Market Drivers: Impact Analysis (2022-2029)
  • Table 2 Global AI in Genomics Market Restraints: Impact Analysis (2022-2029)
  • Table 3 Global AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 4 Global Artificial Intelligence in Genomics Software Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 5 Global AI in Genomics Services Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 6 Global AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 7 Global AI in Genomics Market Size for Cloud & Web-Based Mode, by Country/Region, 2020-2029 (USD Million)
  • Table 8 Global AI in Genomics Market Size for On-Premise Mode, by Country/Region, 2020-2029 (USD Million)
  • Table 9 Global AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 10 Global AI in Genomics Market Size for Genome Sequencing, by Country/Region, 2020-2029 (USD Million)
  • Table 11 Global AI in Genomics Market Size for Gene Editing, by Country/Region, 2020-2029 (USD Million)
  • Table 12 Global AI in Genomics Market Size for Other Functionalities, by Country/Region, 2020-2029 (USD Million)
  • Table 13 Global AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 14 Global AI in Genomics Market Size for Drug Discovery & Development, by Country/Region, 2020-2029 (USD Million)
  • Table 15 Global AI in Genomics Market Size for Precision Medicine, by Country/Region, 2020-2029 (USD Million)
  • Table 16 Global Artificial Intelligence in Genomics Market Size for Diagnostics, by Country/Region, 2020-2029 (USD Million)
  • Table 17 Global AI in Genomics Market Size for Other Applications, by Country/Region, 2020-2029 (USD Million)
  • Table 18 Global AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 19 Global AI in Genomics Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2020-2029 (USD Million)
  • Table 20 Global AI in Genomics Market Size for Academic & Research Institutes, by Country/Region, 2020-2029 (USD Million)
  • Table 21 Global AI in Genomics Market Size for Other End Users, by Country/Region, 2020-2029 (USD Million)
  • Table 22 Global AI in Genomics Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 23 North America: AI in Genomics Market Size, by Country, 2020-2029 (USD Million)
  • Table 24 North America: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 25 North America: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 26 North America: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 27 North America: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 28 North America: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 29 U.S.: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 30 U.S.: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 31 U.S.: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 32 U.S.: Artificial Intelligence in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 33 U.S.: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 34 Canada.: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 35 Canada: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 36 Canada: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 37 Canada: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 38 Canada.: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 39 Europe: AI in Genomics Market Size, by Country/Region, 2022-2029 (USD Million))
  • Table 40 Europe: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 41 Europe: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 42 Europe: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 43 Europe: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 44 Europe: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 45 Germany: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 46 Germany: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 47 Germany: Artificial Intelligence in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 48 Germany: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 49 Germany: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 50 France: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 51 France: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 52 France: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 53 France: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 54 France: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 55 U.K.: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 56 U.K.: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 57 U.K.: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 58 U.K.: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 59 U.K.: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 60 Italy: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 61 Italy: Artificial Intelligence in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 62 Italy: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 63 Italy: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 64 Italy: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 65 Spain: AI in Genomics Market Size, by Offerings, 2020-2029 (USD Million)
  • Table 66 Spain: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 67 Spain: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 68 Spain: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 69 Spain: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 70 Rest of Europe: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 71 Rest of Europe: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 72 Rest of Europe: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 73 Rest of Europe: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 74 Rest of Europe: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 75 Asia-Pacific: AI in Genomics Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 76 Asia-Pacific: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 77 Asia-Pacific: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 78 Asia-Pacific: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 79 Asia-Pacific: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 80 Asia-Pacific: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 81 China: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 82 China: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 83 China: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 84 China: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 85 China: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 86 Japan: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 87 Japan: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 88 Japan: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 89 Japan: AI in Market Size, by Application, 2020-2029 (USD Million)
  • Table 90 Japan: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 91 India: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 92 India: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 93 India: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 94 India: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 95 India: Artificial Intelligence in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 96 Rest of Asia Pacific: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 97 Rest of Asia Pacific: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 98 Rest of Asia Pacific: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 99 Rest of Asia Pacific: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 100 Rest of Asia Pacific: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 101 Latin America: AI in Genomics Market Size, by Country/Region, 2020-2029 (USD Million)
  • Table 102 Latin America: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 103 Latin America: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 104 Latin America: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 105 Latin America: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 106 Latin America: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 107 Brazil: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 108 Brazil: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 109 Brazil: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 110 Brazil: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 111 Brazil: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 112 Mexico: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 113 Mexico: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 114 Mexico: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 115 Mexico: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 116 Mexico: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 117 Rest of Latin America: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 118 Rest of Latin America: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 119 Rest of Latin America: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 120 Rest of Latin America: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 121 Rest of Latin America: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 122 Middle East & Africa: AI in Genomics Market Size, by Offering, 2020-2029 (USD Million)
  • Table 123 Middle East & Africa: AI in Genomics Market Size, by Delivery Mode, 2020-2029 (USD Million)
  • Table 124 Middle East & Africa: AI in Genomics Market Size, by Functionality, 2020-2029 (USD Million)
  • Table 125 Middle East & Africa: AI in Genomics Market Size, by Application, 2020-2029 (USD Million)
  • Table 126 Middle East & Africa: AI in Genomics Market Size, by End User, 2020-2029 (USD Million)
  • Table 127 Recent Developments, by Company, 2020-2022

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global AI in Genomics Market Size, by Offering, 2022-2029 (USD Million)
  • Figure 8 Global Artificial Intelligence in Genomics Market Size, by Delivery Mode, 2022-2029 (USD Million)
  • Figure 9 Global AI in Genomics Market Size, by Functionality, 2022-2029 (USD Million)
  • Figure 10 Global AI in Genomics Market Size, by Application, 2022-2029 (USD Million)
  • Figure 11 Global AI in Genomics Market Size, by End User, 2022-2029 (USD Million)
  • Figure 12 Global AI in Genomics Market, by Geography
  • Figure 13 Market Dynamics: AI in Genomics Market
  • Figure 14 Global Rise in the Number of Personalized Medicines, 2008-2020
  • Figure 15 Global AI in Genomics Market Size, by Offering, 2022 Vs. 2029 (USD Million)
  • Figure 16 Global AI in Genomics Market Size, by Delivery Mode, 2022 Vs. 2029 (USD Million)
  • Figure 17 Global AI in Genomics Market Size, by Functionality, 2022 Vs. 2029 (USD Million)
  • Figure 18 Global AI in Genomics Market Size, by Application, 2022 Vs. 2029 (USD Million)
  • Figure 19 Global AI in Genomics Market Size, by End User, 2022 Vs. 2029 (USD Million)
  • Figure 20 Global AI in Genomics Market Size, by Geography, 2022-2029 (USD Million)
  • Figure 21 North America: AI in Genomics Market Snapshot
  • Figure 22 Europe: AI in Genomics Market Snapshot
  • Figure 23 Asia-Pacific: AI in Genomics Market Size Snapshot
  • Figure 24 Latin America: AI in Genomics Market Size Snapshot
  • Figure 25 Key Growth Strategies Adopted by Leading Players, 2020-2022
  • Figure 26 AI in Genomics Market: Competitive Benchmarking by Functionality
  • Figure 27 AI in Genomics Market: Competitive Benchmarking by Geography
  • Figure 28 Market Share Analysis: AI in Genomics Market, 2021
  • Figure 29 Microsoft Corporation: Financial Overview (2022)
  • Figure 30 NVIDIA Corporation: Financial Overview (2022)
  • Figure 31 Predictive Oncology Inc.: Financial Overview (2021)
  • Figure 32 SOPHiA GENETICS SA: Financial Overview (2021)
  • Figure 33 Illumina, Inc.: Financial Overview (2021)
  • Figure 34 BenevolentAI Limited: Financial Overview (2021)